Upgrades/Downgrades
Updated: 23-Oct-26 09:46 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Valley National | VLY | Keefe Bruyette | Mkt Perform » Outperform | $17 | |
| Roche Hldg | RHHBY | Deutsche Bank | Hold » Buy | ||
| Pharvaris N.V. | PHVS | BofA Securities | Neutral » Buy | $44 | |
| MSC Industrial | MSM | Stephens | Equal-Weight » Overweight | $135 | |
| MSC Industrial | MSM | Jefferies | Hold » Buy | $135 | |
| Hess Midstream Partners | HESM | Raymond James | Mkt Perform » Outperform | $32 | |
| Allegion | ALLE | BofA Securities | Neutral » Buy | $200 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Old Republic | ORI | Raymond James | Strong Buy » Outperform | $45 | |
| NVR | NVR | BofA Securities | Buy » Underperform | $5900 | |
| Norwegian Cruise Line | NCLH | JP Morgan | Neutral » Underweight | $11 | |
| Globe Life | GL | Piper Sandler | Overweight » Neutral | $165 | |
| First Industrial Realty | FR | Raymond James | Strong Buy » Outperform | $71 | |
| Deckers Outdoor | DECK | Piper Sandler | Neutral » Underweight | $75 | |
| Cass Information Systems | CASS | Raymond James | Outperform » Mkt Perform | ||
| Avalo Therapeutics | AVTX | H.C. Wainwright | Buy » Neutral | ||
| Avalo Therapeutics | AVTX | Guggenheim | Buy » Neutral | ||
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| VSE Corp | VSEC | KeyBanc Capital Markets | Sector Weight | ||
| Super Group | SGHC | Barclays | Equal Weight | $13 | |
| Rush Street Interactive | RSI | Barclays | Overweight | $24 | |
| Quantum | QMCO | Cantor Fitzgerald | Overweight | $29 | |
| Natera | NTRA | Roth Capital | Buy | $475 | |
| Microbot Medical | MBOT | Citizens | Mkt Outperform | $2.50 | |
| Kimberly-Clark | KMB | Canaccord Genuity | Hold | $105 | |
| Immunic | IMUX | Cantor Fitzgerald | Overweight | ||
| Guardant Health | GH | Roth Capital | Buy | $200 | |
| Diodes | DIOD | Needham | Buy | $110 | |
| CAMP4 Therapeutics | CAMP | Raymond James | Strong Buy | $10 | |
| Benitec Biopharma | BNTC | Raymond James | Outperform | $14 | |
| Astronics | ATRO | KeyBanc Capital Markets | Sector Weight | ||
| Abundia Global Impact Group | AGIG | Roth Capital | Buy | $3 | |
| Unusual Machines | UMAC | Northland Capital | Outperform | $30 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Benchmark Electronics | BHE | Needham | Buy | $85 | |
| Skydance | SKYD | JP Morgan | Neutral | $9 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |